ArticlePloS one2026

Development and validation of a nomogram predicting pathologic complete response to neoadjuvant chemotherapy in luminal type breast cancer patients using MammaPrint® and clinicopathological factor.

Sarah Al Safi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.